Product Introduction
Bioactivity


英文名: AZ12672857

描述: AZ12672857 是一种 EphB4 抑制剂，IC50 为 1.3 nM。 AZ12672857 抑制 Src 转染 3T3 细胞的细胞增殖，IC50 为 2 nM，抑制转染 CHO-K1 细胞中 EphB4 的自磷酸化，IC50 为 9 nM。

体外活性: AZ12672857 shows IC50s of 240 nM and 58 nM for p-KDR in HUVEC and p-PDGFR-β in MG63 cell line. AZ12672857 moderately inhibits CYP P450 with IC50s of 5 μM for 2C9 and 3A4 and >10 μM for 1A4, 2D6 and 2C19[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 20 mg/mL (41.1 mM)


关键字: AZ12672857 | AZ-12672857 | AZ 12672857

相关产品: CH6953755 | Vemurafenib | PP121 | 5Z-7-Oxozeaenol | Spebrutinib | Tolimidone | LCB 03-0110 dihydrochloride | Agerafenib | A-770041 | Dasatinib

相关库: Anti-Cancer Metabolism Compound Library | Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Inhibitor Library | Tyrosine Kinase Inhibitor Library | Anti-Pancreatic Cancer Compound Library | Bioactive Compound Library